rs1799963, F2

N. diseases: 25
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
0.010 GeneticVariation BEFREE We compared the incidence of cancer diagnosis during follow-up among cohort women positive for antiphospholipid antibodies (n=517), cohort women carrying the F5 rs6025 or F2 rs1799963 polymorphism (n=279) and cohort women with negative thrombophilia screening results (n=796). 31101755 2020
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.010 GeneticVariation BEFREE We compared the incidence of cancer diagnosis during follow-up among cohort women positive for antiphospholipid antibodies (n=517), cohort women carrying the F5 rs6025 or F2 rs1799963 polymorphism (n=279) and cohort women with negative thrombophilia screening results (n=796). 31101755 2020
Myocardial Infarction
CUI: C0027051
Disease: Myocardial Infarction
0.010 GeneticVariation BEFREE Prothrombin G20210A (rs1799963) polymorphism increases myocardial infarction risk in an age-related manner: A systematic review and meta-analysis. 29051591 2017
Fetal Growth Retardation
CUI: C0015934
Disease: Fetal Growth Retardation
0.010 GeneticVariation BEFREE A combination of alleles G of rs1799963, A of rs6046, and G of rs1800790 (OR = 0.31) reduces the risk of FGR. 28544373 2017
Cardiovascular Diseases
CUI: C0007222
Disease: Cardiovascular Diseases
0.010 GeneticVariation BEFREE A total of nine gene variants/polymorphisms - F5 (Leiden - R5 06Q, rs6025), F2 (20210G > A, rs1799963), F13A1 (V34L, rs5985), MTHFR (677C > T - A222V, rs1801133), MTHFR (1298A > C - E429A, rs1801131), FGB (-455G > A -c.-463G > A; rs1800790), SERPINE1 (PAI14G/5G - rs1799889), ACE (ACE I/D, rs1799752), ITGB3 (GPIIIa L33P, rs5918) and the APOE E2/E3/E4 alleles (rs7412, rs429358) - were genotyped in 200 newly diagnosed ischemic stroke (IS) patients, 165 patients with ischemic coronary heart disease (CHD) and 159 controls with no cerebroor cardiovascular disease (non-CVD). 27629735 2016
Factor V Leiden mutation
CUI: C0584960
Disease: Factor V Leiden mutation
0.010 GeneticVariation BEFREE To assess Factor V Leiden (FVL) (rs6025), Prothrombin G20210A (rs1799963), MTHFR C677T (rs1801133), and MTHFR A1298C (rs1801131) gene mutations as risk factors in the development of retinopathy of prematurity (ROP). 27018927 2016
Retinopathy of Prematurity
CUI: C0035344
Disease: Retinopathy of Prematurity
0.010 GeneticVariation BEFREE To assess Factor V Leiden (FVL) (rs6025), Prothrombin G20210A (rs1799963), MTHFR C677T (rs1801133), and MTHFR A1298C (rs1801131) gene mutations as risk factors in the development of retinopathy of prematurity (ROP). 27018927 2016
Juvenile Myoclonic Epilepsy
CUI: C0270853
Disease: Juvenile Myoclonic Epilepsy
0.010 GeneticVariation BEFREE These results present no evidence for an association of rs1799963 with JME. 25992517 2015
Severe hereditary factor VIII deficiency disease
0.010 GeneticVariation BEFREE The present cohort study was performed to investigate the impact of the factor 5 rs6025 [F5] and the factor 2 rs1799963 [F2] mutations on high-titer inhibitor development [HRI] in patients with severe/moderate-severe hemophilia A [HA]. 24485400 2014
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
0.010 GeneticVariation BEFREE The prothrombotic polymorphisms factor V Leiden (rs6025) and prothrombin G20210A (rs1799963) were not associated with breast cancer. 25407022 2014
Malignant neoplasm of breast
CUI: C0006142
Disease: Malignant neoplasm of breast
0.010 GeneticVariation BEFREE The prothrombotic polymorphisms factor V Leiden (rs6025) and prothrombin G20210A (rs1799963) were not associated with breast cancer. 25407022 2014
Hemophilia A
CUI: C0019069
Disease: Hemophilia A
0.010 GeneticVariation BEFREE Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database study. 24485400 2014
Protein S Deficiency
CUI: C0242666
Disease: Protein S Deficiency
0.010 GeneticVariation BEFREE We investigated the prevalence of the factor V Leiden (F5 rs6025) and prothrombin gene G20210A (F2 rs1799963) polymorphisms, and antithrombin, protein C and protein S deficiencies, and their association with intrauterine fetal death. 22198364 2011
Lupus Erythematosus, Systemic
CUI: C0024141
Disease: Lupus Erythematosus, Systemic
0.010 GeneticVariation BEFREE While the rs1799963 A allele was almost absent in African Americans, it was present at ~2% frequency in Caucasian Americans and showed no significant association with SLE. 21239755 2011
Thrombophilia
CUI: C0398623
Disease: Thrombophilia
0.040 GeneticVariation BEFREE We compared the incidence of cancer diagnosis during follow-up among cohort women positive for antiphospholipid antibodies (n=517), cohort women carrying the F5 rs6025 or F2 rs1799963 polymorphism (n=279) and cohort women with negative thrombophilia screening results (n=796). 31101755 2020
Thrombophilia
CUI: C0398623
Disease: Thrombophilia
0.040 GeneticVariation BEFREE Apart from underlying medical conditions, recently reported systematic reviews on pediatric VTE (70% provoked) have shown significant associations between thrombosis and presence of protein C-, protein S- and antithrombin deficiency, factor 5 (F5: rs6025), factor 2 (F2: rs1799963), even more pronounced when combined inherited thrombophilias [IT] were involved. 28010922 2017
Thrombophilia
CUI: C0398623
Disease: Thrombophilia
0.040 GeneticVariation BEFREE We compared the frequencies of complications during a new pregnancy attempt among women carrying the F5 rs6025 or F2 rs1799963 polymorphism (n = 279; low-molecular-weight heparin [LMWH] treatment during pregnancy only in case of prior fetal death), and women with negative thrombophilia screening results as control women (n = 796; no treatment). 24200686 2014
Thrombophilia
CUI: C0398623
Disease: Thrombophilia
0.040 GeneticVariation BEFREE We compared the frequencies of thrombotic events among women positive for antiphospholipid Abs (n = 517), women carrying the F5 6025 or F2 rs1799963 polymorphism (n = 279), and women with negative thrombophilia screening results (n = 796). 22147897 2012
Deep Vein Thrombosis
CUI: C0149871
Disease: Deep Vein Thrombosis
0.700 GeneticVariation GWASCAT Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. 26908601 2016
Pulmonary Embolism
CUI: C0034065
Disease: Pulmonary Embolism
0.700 GeneticVariation GWASCAT Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. 26908601 2016
THROMBOPHILIA DUE TO THROMBIN DEFECT
0.700 CausalMutation CLINVAR A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice. 23429074 2013
THROMBOPHILIA DUE TO THROMBIN DEFECT
0.700 CausalMutation CLINVAR Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability. 21349849 2011
THROMBOPHILIA DUE TO THROMBIN DEFECT
0.700 CausalMutation CLINVAR Effect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells. 21243428 2011
THROMBOPHILIA DUE TO THROMBIN DEFECT
0.700 CausalMutation CLINVAR HFE polymorphisms affect cellular glutamate regulation. 19560233 2011
THROMBOPHILIA DUE TO THROMBIN DEFECT
0.700 CausalMutation CLINVAR HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. 19554541 2009